Base editing the mammalian genome

被引:14
作者
Schatoff, Emma M. [1 ,4 ]
Zafra, Maria Paz [1 ,2 ]
Dow, Lukas E. [1 ,2 ,3 ]
机构
[1] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA
[2] Dept Med, New York, NY USA
[3] Weill Cornell Med, Dept Biochem, New York, NY 10021 USA
[4] Weill Cornell Rockefeller Sloan Kettering Tri I M, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
BE; Base editing; CRISPR; APOBEC; CRISPR-CAS9; NUCLEASES; DNA; RICE;
D O I
10.1016/j.ymeth.2019.02.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Base editing is a powerful technology that enables programmable conversion of single nucleotides in the mammalian genome. Base editors consist of a partially active Cas9 nuclease (Cas9(D10A)) tethered to a natural or synthetic DNA modifying enzyme. Though only recently described, BE has already shown enormous potential for basic and translational research, allowing the creation or repair of disease alleles in a variety of cell types and model organisms. In the past 2 years, a vast array of new and modified base editor variants have been described, expanding the flexibility and usefulness of the approach. Though simple in concept, effective implementation of base editing requires an understanding of the advantages and limitations of each of these tools. Here, we provide an overview of the concepts of DNA base editing, and discuss the recent progress toward the development of optimized base editing systems for mammalian cells. In addition, we highlight key technical aspects of designing and executing BE experiments, and provide detailed experimental examples of successful base editing in cell lines and organoids to help guide the effective use of these tools for genome modification.
引用
收藏
页码:100 / 108
页数:9
相关论文
共 37 条
  • [1] Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
    Annunziato, Stefano
    Kas, Sjors M.
    Nethe, Micha
    Yucel, Hatice
    Del Bravo, Jessica
    Pritchard, Colin
    Bin Ali, Rahmen
    van Gerwen, Bas
    Siteur, Bjorn
    Drenth, Anne Paulien
    Schut, Eva
    van de Ven, Marieke
    Boelens, Mirjam C.
    Klarenbeek, Sjoerd
    Huijbers, Ivo J.
    van Miltenburg, Martine H.
    Jonkers, Jos
    [J]. GENES & DEVELOPMENT, 2016, 30 (12) : 1470 - 1480
  • [2] In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing
    Chadwick, Alexandra C.
    Wang, Xiao
    Musunuru, Kiran
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (09) : 1741 - +
  • [3] Clement K., 2018, ANAL COMP GENOME EDI
  • [4] Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
    Gaudelli, Nicole M.
    Komor, Alexis C.
    Rees, Holly A.
    Packer, Michael S.
    Badran, Ahmed H.
    Bryson, David I.
    Liu, David R.
    [J]. NATURE, 2017, 551 (7681) : 464 - +
  • [5] An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities
    Gehrke, Jason M.
    Cervantes, Oliver
    Clement, M. Kendell
    Wu, Yuxuan
    Zeng, Jing
    Bauer, Daniel E.
    Pinello, Luca
    Joung, J. Keith
    [J]. NATURE BIOTECHNOLOGY, 2018, 36 (10) : 977 - +
  • [6] Gurumurthy C., 2018, REEVALUATING ONE STE
  • [7] Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
    Hu, Johnny H.
    Miller, Shannon M.
    Geurts, Maarten H.
    Tang, Weixin
    Chen, Liwei
    Sun, Ning
    Zeina, Christina M.
    Gao, Xue
    Rees, Holly A.
    Lin, Zhi
    Liu, David R.
    [J]. NATURE, 2018, 556 (7699) : 57 - +
  • [8] Highly efficient RNA-guided base editing in mouse embryos
    Kim, Kyoungmi
    Ryu, Seuk-Min
    Kim, Sang-Tae
    Baek, Gayoung
    Kim, Daesik
    Lim, Kayeong
    Chung, Eugene
    Kim, Sunghyun
    Kim, Jin-Soo
    [J]. NATURE BIOTECHNOLOGY, 2017, 35 (05) : 435 - +
  • [9] Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions
    Kim, Y. Bill
    Komor, Alexis C.
    Levy, Jonathan M.
    Packer, Michael S.
    Zhao, Kevin T.
    Liu, David R.
    [J]. NATURE BIOTECHNOLOGY, 2017, 35 (04) : 371 - +
  • [10] High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
    Kleinstiver, Benjamin P.
    Pattanayak, Vikram
    Prew, Michelle S.
    Tsai, Shengdar Q.
    Nguyen, Nhu T.
    Zheng, Zongli
    Joung, J. Keith
    [J]. NATURE, 2016, 529 (7587) : 490 - +